BNP Paribas Financial Markets’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-20,503
Closed -$772K 3505
2021
Q1
$772K Buy
20,503
+15,657
+323% +$590K ﹤0.01% 1804
2020
Q4
$82.4K Sell
4,846
-1,597
-25% -$27.2K ﹤0.01% 2664
2020
Q3
$30.3K Buy
6,443
+5,529
+605% +$26K ﹤0.01% 3055
2020
Q2
$5.58K Sell
914
-9,692
-91% -$59.1K ﹤0.01% 3333
2020
Q1
$24.1K Buy
10,606
+2,311
+28% +$5.25K ﹤0.01% 3242
2019
Q4
$38.1K Buy
8,295
+2,940
+55% +$13.5K ﹤0.01% 3129
2019
Q3
$20.8K Buy
5,355
+1,646
+44% +$6.38K ﹤0.01% 3292
2019
Q2
$22.4K Sell
3,709
-3,619
-49% -$21.8K ﹤0.01% 3231
2019
Q1
$98.2K Buy
7,328
+6,967
+1,930% +$93.4K ﹤0.01% 2557
2018
Q4
$3.36K Sell
361
-1,139
-76% -$10.6K ﹤0.01% 3022
2018
Q3
$20.9K Buy
1,500
+72
+5% +$1K ﹤0.01% 2735
2018
Q2
$22.6K Sell
1,428
-5,377
-79% -$85K ﹤0.01% 2804
2018
Q1
$117K Buy
6,805
+1,155
+20% +$19.8K ﹤0.01% 2533
2017
Q4
$124K Buy
5,650
+2,642
+88% +$57.9K ﹤0.01% 2542
2017
Q3
$123K Sell
3,008
-219
-7% -$8.96K ﹤0.01% 2325
2017
Q2
$97.2K Sell
3,227
-91
-3% -$2.74K ﹤0.01% 2417
2017
Q1
$120K Sell
3,318
-1,810
-35% -$65.4K ﹤0.01% 2052
2016
Q4
$257K Buy
5,128
+3,287
+179% +$165K ﹤0.01% 1753
2016
Q3
$96.6K Buy
1,841
+787
+75% +$41.3K ﹤0.01% 2124
2016
Q2
$43.6K Buy
+1,054
New +$43.6K ﹤0.01% 2339
2016
Q1
Sell
-4,742
Closed -$197K 3259
2015
Q4
$197K Buy
4,742
+358
+8% +$14.9K ﹤0.01% 1936
2015
Q3
$67.5K Sell
4,384
-231,615
-98% -$3.56M ﹤0.01% 2647
2015
Q2
$5.86M Buy
235,999
+235,652
+67,911% +$5.85M 0.02% 549
2015
Q1
$7.93K Buy
+347
New +$7.93K ﹤0.01% 2880
2014
Q4
Sell
-1,066
Closed -$12.5K 3040
2014
Q3
$12.5K Buy
+1,066
New +$12.5K ﹤0.01% 2985